Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. .
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Marques-Lespier JM, Gonzalez-Pons M, Cruz-Correa M. Current perspectives on gastric Cancer. Gastroenterol Clin North Am. 2016;45(3):413–428.
   PubMed Web of Science ®Google Scholar
• Gai Z, Gui T, Muragaki Y. The function of TRPS1 in the development and differentiation of bone, kidney, and hair follicles. Histol Histopathol. 2011;26(7):915–921.
   PubMed Web of Science ®Google Scholar
• Wilke CM, Hess J, Klymenko SV, et al. Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer. Int J Cancer. 2018;142(3):573–583.
   PubMed Web of Science ®Google Scholar
• Hu J, Su P, Jiao M, et al. TRPS1 suppresses breast cancer epithelial-mesenchymal transition program as a negative regulator of SUZ12. Transl Oncol. 2018;11(2):416–425.
   PubMed Web of Science ®Google Scholar
• Rangel R, Lee SC, Hon-Kim Ban K, et al. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression. 2016;113(48):E7749–e7758.
   Google Scholar
• Wu L, Wang Y, Liu Y, et al. A central role for TRPS1 in the control of cell cycle and cancer development. Oncotarget. 2014;5(17):7677–7690.
   PubMedGoogle Scholar
• Bach AS, Derocq D, Laurent-Matha V, et al. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells. Oncotarget. 2015;6(29):28084–28103.
   PubMedGoogle Scholar
• Stinson S, Lackner MR, Adai AT, et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal. 2011;4(186):pt5.
   PubMed Web of Science ®Google Scholar
• Hong J, Sun J, Huang T. Increased expression of TRPS1 affects tumor progression and correlates with patients’ prognosis of colon cancer. Biomed Res Int. 2013;2013:454085.
   PubMed Web of Science ®Google Scholar
• Fischer SB, Attenhofer M, Gultekin SH, et al. TRPS1 gene alterations in human subependymoma. J Neurooncol. 2017;134(1):133–138.
   PubMed Web of Science ®Google Scholar
• Huang ML, Wu H, Lu ZL. Expression of TRPS1 in gastric cancer and its bioinformatics analysis. Snake. 2019;31(2):188–192+ 201. (Chinese).
   Google Scholar
• Fan D. Expression of TRPS1 in epithelial ovarian cancer and its clinical significance [D]. China Medical University; 2018. (Chinese).
   Google Scholar
• Zhang L, Luo B, He RQ, et al. Clinical significance of microRNA-196b-5p in hepatocellular carcinoma and its potential molecular mechanism. J Cancer. 2019;10(22):5355–5370.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang LJ, Li SH, et al. Role of miR-452-5p in the tumorigenesis of prostate cancer: a study based on the cancer genome atl (TCGA), gene expression omnibus (GEO), and bioinformatics analysis. Pathol Res Pract. 2018;214(5):732–749.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li XJ, He RQ, et al. Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: a comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis. Int J Oncol. 2018;53(1):73–86.
   PubMed Web of Science ®Google Scholar
• He RQ, Wu PR, Xiang XL, et al. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: a study based on public data and RT-qPCR verification. Int J Mol Med. 2018;41(5):2813–2831.
   PubMed Web of Science ®Google Scholar
• Tremblay M, Sanchez-Ferras O, Bouchard M. GATA transcription factors in development and disease. Development. 2018;145:20.
   Web of Science ®Google Scholar
• Su P, Hu J, Zhang H, et al. Association of TRPS1 gene with different EMT markers in ERalpha-positive and ERalpha-negative breast cancer. Diagn Pathol. 2014;9:119.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Bao Y, Litton J, et al. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer. Horm Cancer. 2011;2(2):132–143.
   PubMedGoogle Scholar
• Lin HY, Zeng, Liang YK, et al. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies. Oncotarget. 2017;8(21):34750–34761.
   PubMedGoogle Scholar
• Hu J, Su P, Jia M, et al. TRPS1 expression promotes angiogenesis and affects VEGFA expression in breast cancer. Exp Biol Med (Maywood). 2014;239(4):423–429.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin X, Gong X, et al. Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression. Oncogenesis. 2018;7(12):96.
   PubMedGoogle Scholar
• Lee-Six H, Øbro NF, Shepherd MS, et al. Population dynamics of normal human blood inferred from somatic mutations. Nature. 2018;561(7724):473–478.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565(7739):312–317.
   PubMed Web of Science ®Google Scholar
• Martincorena I, Fowler JC, Wabik A, et al. Somatic mutant clones colonize the human esophagus with age. Science (New York, NY). 2018;362(6417):911–917.
   Google Scholar
• Panarese I, De Vita F, Ronchi A, et al. Predictive biomarkers along gastric cancer pathogenetic pathways. Expert Rev Anticancer Ther. 2017;17(5):417–425.
   PubMed Web of Science ®Google Scholar
• Karimi Kurdistani Z, Saberi S, Tsai KW, et al. MicroRNA-21: mechanisms of oncogenesis and its application in diagnosis and prognosis of gastric cancer. Arch Iran Med. 2015;18(8):524–536.
   PubMed Web of Science ®Google Scholar
• Wang F, Meng W, Wang B, et al. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202.
   PubMed Web of Science ®Google Scholar
• Chen D, Liu G, Xu N, et al. Knockdown of ARK5 expression suppresses invasion and metastasis of gastric cancer. Cell Physiol Biochem. 2017;42(3):1025–1036.
   PubMedGoogle Scholar
• You W, Xu L, Zhang X, et al. High-throughput screening identifies miR-451 as a pleiotropic modulator that suppresses gastric cancer metastasis. SLAS Technol. 2017;22(2):136–143.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li X, Yuan H. microRNAs in gastric cancer invasion and metastasis. Front Biosci (Landmark Ed). 2013;18:803–810.
   PubMed Web of Science ®Google Scholar
• Wuelling M, Pasdziernik M, Moll CN, et al. The multi zinc-finger protein Trps1 acts as a regulator of histone deacetylation during mitosis. Cell Cycle. 2013;12(14):2219–2232.
   PubMed Web of Science ®Google Scholar
• Huang JZ, Chen M, Zeng M, et al. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1. J Pathol. 2016;239(2):186–196.
   PubMed Web of Science ®Google Scholar
• Huang R, Zong X. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: mechanisms in cancer progression. Crit Rev Oncol Hematol. 2017;115:13–22.
   PubMed Web of Science ®Google Scholar
• Liu Y. Mechanism of mir-221 targeting TRPS1 protein regulating biological behavior of non-small cell lung cancer [d]. Zhengzhou University; 2018. (Chinese).
   Google Scholar
• Witwicki RM, Ekram MB, Qiu X, et al. TRPS1 is a lineage-Specific transcriptional dependency in breast cancer. Cell Rep. 2018;25(5):1255–1267.e1255.
   PubMed Web of Science ®Google Scholar
• Li L, Zhu Z, Zhao Y, et al. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Sci Rep. 2019;9(1):7827.
   PubMedGoogle Scholar
• Zhang H, Sun Z, Li Y, et al. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacothe. 2017;88:285–292. (undefined).
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Xu G, et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut. 2015;64(2):203–214.
   PubMed Web of Science ®Google Scholar